{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:08:37Z","timestamp":1793423317460,"version":"4.5.0"},"reference-count":398,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007743","name":"European Society for Clinical Nutrition and Metabolism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007743","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.clnu.2023.12.017","type":"journal-article","created":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T11:40:52Z","timestamp":1703677252000},"page":"413-445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":125,"title":["ESPEN-ESPGHAN-ECFS guideline on nutrition care for cystic fibrosis"],"prefix":"10.1016","volume":"43","author":[{"given":"Michael","family":"Wilschanski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2331-278X","authenticated-orcid":false,"given":"Anne","family":"Munck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefania","family":"Carrion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5652-7248","authenticated-orcid":false,"given":"Marco","family":"Cipolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1282-9476","authenticated-orcid":false,"given":"Sarah","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8975-695X","authenticated-orcid":false,"given":"Carla","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0857-874X","authenticated-orcid":false,"given":"Dimitri","family":"Declercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9505-2054","authenticated-orcid":false,"given":"Elpis","family":"Hatziagorou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4899-7343","authenticated-orcid":false,"given":"Jessie","family":"Hulst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daina","family":"Kalnins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina N.","family":"Katsagoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen G.","family":"Mainz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Ribes-Koninckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Van Biervliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chourdakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2023.12.017_bib1","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1177\/0884533613507086","article-title":"Malnutrition in cystic fibrosis","volume":"28","author":"Culhane","year":"2013","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnu.2023.12.017_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3476(05)83478-X","article-title":"The changing epidemiology of cystic fibrosis","volume":"122","author":"FitzSimmons","year":"1993","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2023.12.017_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcf.2006.05.008","article-title":"A\u00a0survey of newborn screening for cystic fibrosis in Europe","volume":"6","author":"Southern","year":"2007","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2023.12.017_bib4","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jcf.2008.03.007","article-title":"The prevalence of cystic fibrosis in the European Union","volume":"7","author":"Farrell","year":"2008","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2023.12.017_bib5","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1164\/rccm.201009-1478CI","article-title":"Managing cystic fibrosis","volume":"183","author":"Cohen-Cymberknoh","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clnu.2023.12.017_bib6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.dld.2014.06.011","article-title":"Digestive system dysfunction in cystic fibrosis: challenges for nutrition therapy","volume":"46","author":"Li","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clnu.2023.12.017_bib7","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.clnu.2015.07.008","article-title":"Standard operating procedures for ESPEN guidelines and consensus papers","volume":"34","author":"Bischoff","year":"2015","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.clnu.2016.03.004","article-title":"ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis","volume":"35","author":"Turck","year":"2016","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib9","series-title":"Sign 50: a guideline developer's handbook","article-title":"Revised version","year":"2014"},{"key":"10.1016\/j.clnu.2023.12.017_bib10","series-title":"St\u00e4ndige Kommission Leitlinien. AWMF-regelwerk","year":"2012"},{"key":"10.1016\/j.clnu.2023.12.017_bib11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jcf.2016.12.001","article-title":"Differences between WHO AND CDC early growth measurements in the assessment of Cystic Fibrosis clinical outcomes","volume":"16","author":"Usatin","year":"2017","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.nut.2015.10.012","article-title":"Body composition and lung function in cystic fibrosis and their association with adiposity and normal-weight obesity","volume":"32","author":"Alvarez","year":"2016","journal-title":"Nutrition"},{"key":"10.1016\/j.clnu.2023.12.017_bib13","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/ppul.24343","article-title":"Rapid early increase in BMI is associated with impaired longitudinal growth in children with cystic fibrosis","volume":"54","author":"Hak","year":"2019","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.clnu.2023.12.017_bib14","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/0884533616639109","article-title":"Height assessment in the Dutch-origin pediatric cystic fibrosis population","volume":"32","author":"Woestenenk","year":"2017","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnu.2023.12.017_bib15","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/MPG.0000000000000610","article-title":"Comparison of WHO and CDC growth charts in predicting pulmonary outcomes in cystic fibrosis","volume":"60","author":"Machogu","year":"2015","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib16","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jpeds.2015.07.036","article-title":"Comparing the use of centers for disease control and prevention and world health organization growth charts in children with cystic fibrosis through 2 Years of age","volume":"167","author":"Zhang","year":"2015","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2023.12.017_bib17","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1097\/MPG.0000000000002679","article-title":"Comparison of international growth standards for assessing nutritional status in cystic fibrosis: the GreeCF study","volume":"71","author":"Poulimeneas","year":"2020","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib18","article-title":"Nutritional assessment in adults with cystic fibrosis","volume":"67","author":"Sch\u00f6nenberger","year":"2019","journal-title":"Nutrition"},{"key":"10.1016\/j.clnu.2023.12.017_bib19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.clnesp.2021.01.038","article-title":"Changes in handgrip strength in children with cystic fibrosis compared to children without cystic fibrosis","volume":"42","author":"Bellini","year":"2021","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.clnu.2023.12.017_bib20","first-page":"1110","article-title":"The association of grip strength, body mass index, and lung function in youth with cystic fibrosis","volume":"vol. 35","author":"Bouma","year":"2020"},{"key":"10.1016\/j.clnu.2023.12.017_bib21","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.3390\/nu13114107","article-title":"Handgrip strength: associations with clinical variables, body composition, and bone mineral density in adults with cystic fibrosis","volume":"13","author":"Contreras-Bolivar","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2023.12.017_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ncp.10067","article-title":"Evaluating changes in handgrip strength in children with cystic fibrosis: a pilot study","volume":"33","author":"Gibson","year":"2018","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnu.2023.12.017_bib23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.rmed.2018.07.016","article-title":"Nutritional status and pulmonary outcome in children and young people with cystic fibrosis","volume":"142","author":"Papalexopoulou","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.clnu.2023.12.017_bib24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1590\/1984-0462\/;2018;36;4;00015","article-title":"The use of ultrasonography to evaluate muscle thickness and subcutaneous fat in children and adolescents with cystic fibrosis","volume":"36","author":"Souza","year":"2018","journal-title":"Rev Paul Pediatr"},{"key":"10.1016\/j.clnu.2023.12.017_bib25","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jcf.2015.07.011","article-title":"Estimating body composition from skinfold thicknesses and bioelectrical impedance analysis in cystic fibrosis patients","volume":"14","author":"Alicandro","year":"2015","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.nut.2017.10.026","article-title":"Association between body composition and pulmonary function in children and young people with cystic fibrosis","volume":"48","author":"Calella","year":"2018","journal-title":"Nutrition"},{"key":"10.1016\/j.clnu.2023.12.017_bib27","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jcf.2016.05.004","article-title":"Bioelectrical impedance in young patients with cystic fibrosis: validation of a specific equation and clinical relevance","volume":"15","author":"Charatsi","year":"2016","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib28","first-page":"378","article-title":"Nutrition status parameters and hydration status by bioelectrical impedance vector analysis were associated with lung function impairment in children and adolescents with cystic fibrosis","volume":"vol. 31","author":"Hauschild","year":"2016"},{"key":"10.1016\/j.clnu.2023.12.017_bib29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2019.05.018","article-title":"Non-fasting bioelectrical impedance analysis in cystic fibrosis: implications for clinical practice and research","volume":"19","author":"Hollander-Kraaijeveld","year":"2020","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib30","first-page":"789","article-title":"Bone mineral density, lung function, vitamin D and body composition in children and adolescents with cystic fibrosis: a multicenter study","volume":"35","author":"Bravo","year":"2018","journal-title":"Nutr Hosp"},{"key":"10.1016\/j.clnu.2023.12.017_bib31","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jcf.2019.01.002","article-title":"Visceral adipose tissue is associated with poor diet quality and higher fasting glucose in adults with cystic fibrosis","volume":"18","author":"Bellissimo","year":"2019","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib32","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1590\/1413-812320152011.03242015","article-title":"Nutritional status and body fat distribution in children and adolescentes with Cystic Fibrosis","volume":"20","author":"Chaves","year":"2015","journal-title":"Ci\u00eancia Sa\u00fade Coletiva"},{"key":"10.1016\/j.clnu.2023.12.017_bib33","first-page":"376","article-title":"Assessment of body composition in cystic fibrosis: agreement between skinfold measurement and densitometry","volume":"39","author":"Contreras-Bolivar","year":"2022","journal-title":"Nutr Hosp"},{"key":"10.1016\/j.clnu.2023.12.017_bib34","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/ncp.10604","article-title":"Growth, body composition, and lung function in prepubertal children with cystic fibrosis diagnosed by newborn screening","volume":"36","author":"Owen","year":"2021","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnu.2023.12.017_bib35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/MPG.0000000000003437","article-title":"A\u00a0practical approach to identifying pediatric disease-associated undernutrition: a position statement from the ESPGHAN special interest group on clinical malnutrition","volume":"74","author":"Hulst","year":"2022","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib36","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/ncp.10247","article-title":"Tools and methods used for the assessment of body composition in patients with cystic fibrosis: a systematic review","volume":"34","author":"Calella","year":"2019","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnu.2023.12.017_bib37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.nut.2018.03.052","article-title":"Cystic fibrosis, body composition, and health outcomes: a systematic review","volume":"55\u201356","author":"Calella","year":"2018","journal-title":"Nutrition"},{"key":"10.1016\/j.clnu.2023.12.017_bib38","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/ncp.10593","article-title":"Utility of mid-upper arm circumference in diagnosing malnutrition in children with cystic fibrosis","volume":"35","author":"Phong","year":"2020","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnu.2023.12.017_bib39","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/MPG.0b013e318156c2db","article-title":"Validation of a nutrition risk screening tool for children and adolescents with cystic fibrosis ages 2-20 years","volume":"46","author":"McDonald","year":"2008","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib40","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jand.2016.01.012","article-title":"Validation of a nutrition screening tool for pediatric patients with cystic fibrosis","volume":"116","author":"Souza Dos Santos Simon","year":"2016","journal-title":"J\u00a0Acad Nutr Diet"},{"key":"10.1016\/j.clnu.2023.12.017_bib41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.6000\/1929-4247.2015.04.03.1","article-title":"The prospective assessment of nutrition in children with cystic fibrosis","volume":"4","author":"Moeeni","year":"2015","journal-title":"Int J Child Health Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib42","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/children7120269","article-title":"Triage for malnutrition risk among pediatric and adolescent outpatients with cystic fibrosis, using a disease-specific tool","volume":"7","author":"Poulimeneas","year":"2020","journal-title":"Children"},{"key":"10.1016\/j.clnu.2023.12.017_bib43","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0261-5614(02)00214-5","article-title":"Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials","volume":"22","author":"Kondrup","year":"2003","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib44","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jcf.2019.08.028","article-title":"Micronutrient intake in children with cystic fibrosis in Sydney, Australia","volume":"19","author":"Tham","year":"2020","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1017\/S0007114518003021","article-title":"Vitamin D intake, serum 25-hydroxy vitamin D and pulmonary function in paediatric patients with cystic fibrosis: a longitudinal approach","volume":"121","author":"Timmers","year":"2019","journal-title":"Br J Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib46","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.clnu.2015.04.010","article-title":"Vitamin A intake and serum retinol levels in children and adolescents with cystic fibrosis","volume":"35","author":"Woestenenk","year":"2016","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","article-title":"ECFS best practice guidelines: the 2018 revision","volume":"17","author":"Castellani","year":"2018","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2023.12.017_bib48","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jcf.2017.01.010","article-title":"Macronutrient intake in preschoolers with cystic fibrosis and the relationship between macronutrients and growth","volume":"16","author":"Filigno","year":"2017","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib49","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1164\/rccm.201707-1541OC","article-title":"Comparison of nutrition and lung function outcomes in patients with cystic fibrosis living in Canada and the United States","volume":"197","author":"Goss","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clnu.2023.12.017_bib50","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcf.2022.03.010","article-title":"Obesity in Cystic fibrosis: prevalence, trends and associated factors data from the US cystic fibrosis foundation patient registry","volume":"21","author":"Szentpetery","year":"2022","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib51","series-title":"Annual data report","year":"2022"},{"key":"10.1016\/j.clnu.2023.12.017_bib52","first-page":"663A","article-title":"Risk factors for hepatic steatosis in cystic fibrosis are distinct from risk factors for cystic fibrosis liver disease","volume":"66","author":"Ayoub","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2023.12.017_bib53","first-page":"21","article-title":"Growth assessment in Egyptian children with cystic fibrosis: a single center study","volume":"65","author":"El Attar","year":"2017"},{"key":"10.1016\/j.clnu.2023.12.017_bib54","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/j.clnu.2019.12.029","article-title":"Overweight, obesity and significant weight gain in adult patients with cystic fibrosis association with lung function and cardiometabolic risk factors","volume":"39","author":"Bonhoure","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib55","doi-asserted-by":"crossref","first-page":"578","DOI":"10.20960\/nh.620","article-title":"Excess weight in patients with cystic fibrosis: is it always beneficial?","volume":"34","author":"Gonzalez Jimenez","year":"2017","journal-title":"Nutr Hosp"},{"key":"10.1016\/j.clnu.2023.12.017_bib56","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1590\/1984-0462\/;2019;37;4;00007","article-title":"Prevalence of hepatic steatosis among children and adolescents with cystic fibrosis and its association with nutritional status","volume":"37","author":"Gobato","year":"2019","journal-title":"Rev Paul Pediatr"},{"key":"10.1016\/j.clnu.2023.12.017_bib57","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jcf.2021.05.002","article-title":"Overweight and obesity in adults with cystic fibrosis: an Italian multicenter cohort study","volume":"21","author":"Gramegna","year":"2022","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib58","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jcf.2019.10.004","article-title":"Prevalence and factors associated with overweight and obesity in adults with cystic fibrosis: a single-center analysis","volume":"19","author":"Harindhanavudhi","year":"2020","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib59","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1183\/09031936.00119714","article-title":"A\u00a0contemporary survival analysis of individuals with cystic fibrosis: a cohort study","volume":"45","author":"Stephenson","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.clnu.2023.12.017_bib60","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5114\/aoms.2015.49207","article-title":"A\u00a0cross-sectional study of growth, nutritional status and body proportions in children and adolescents at a medical center specializing in the treatment of cystic fibrosis in Poland","volume":"11","author":"Sands","year":"2015","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.clnu.2023.12.017_bib61","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1515\/jpem-2017-0013","article-title":"High attainment of optimal nutritional and growth status observed among Greek pediatric cystic fibrosis patients: results from the GreeCF study","volume":"30","author":"Poulimeneas","year":"2017","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.clnu.2023.12.017_bib62","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1824-7288-40-50","article-title":"Factors influencing quality of life and disease severity in Hungarian children and young adults with cystic fibrosis","volume":"40","author":"Bodnar","year":"2014","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.clnu.2023.12.017_bib63","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s13312-019-1607-2","article-title":"Predictors of malnutrition in children with cystic fibrosis","volume":"56","author":"Dhochak","year":"2019","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.clnu.2023.12.017_bib64","doi-asserted-by":"crossref","first-page":"775","DOI":"10.17219\/acem\/37251","article-title":"s D. Effect of selected factors associated with the clinical course of the disease on nutritional status in children with cystic fibrosis","volume":"23","author":"Um\u0142awska","year":"2014","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.clnu.2023.12.017_bib65","first-page":"63","article-title":"Nutrition status of adult patients with cystic fibrosis","volume":"2014","author":"T\u00f3th","year":"2014","journal-title":"New Med"},{"key":"10.1016\/j.clnu.2023.12.017_bib66","series-title":"ECFSPR annual report 2020","author":"Orenti","year":"2022"},{"key":"10.1016\/j.clnu.2023.12.017_bib67","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/ejcn.2013.20","article-title":"Nutritional care in children with cystic fibrosis: are our patients becoming better?","volume":"67","author":"Gaskin","year":"2013","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib68","series-title":"About child & teen BMI","year":"2022"},{"issue":"3","key":"10.1016\/j.clnu.2023.12.017_bib69","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00408-019-00218-3","article-title":"Nutritional status in childhood as a prognostic factor in patients with cystic fibrosis","volume":"197","author":"Ashkenazi","year":"2019","journal-title":"Lung"},{"key":"10.1016\/j.clnu.2023.12.017_bib70","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ppul.23033","article-title":"Overweight and obesity in patients with cystic fibrosis: a center-based analysis","volume":"50","author":"Hanna","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.clnu.2023.12.017_bib71","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MPG.0000000000001956","article-title":"Nutritional status in the first 2 Years of life in cystic fibrosis diagnosed by newborn screening","volume":"67","author":"Munck","year":"2018","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib72","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/ped.14417","article-title":"The effects of nutritional status and intervention on pulmonary functions in pediatric cystic fibrosis patients","volume":"63","author":"Kilinc","year":"2021","journal-title":"Pediatr Int"},{"key":"10.1016\/j.clnu.2023.12.017_bib73","first-page":"33","article-title":"Body composition and pulmonary function in cystic fibrosis","volume":"2","author":"Sheikh","year":"2014","journal-title":"Front Ped"},{"key":"10.1016\/j.clnu.2023.12.017_bib74","first-page":"1170","article-title":"Early childhood risk factors for decreased FEV1 at age six to seven years in young children with cystic fibrosis","volume":"12","author":"Sanders","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.clnu.2023.12.017_bib75","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jcf.2018.01.006","article-title":"Early life growth patterns persist for 12 years and impact pulmonary outcomes in cystic fibrosis","volume":"17","author":"Sanders","year":"2018","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/nu13124414","article-title":"Most short children with cystic fibrosis do not catch up by adulthood","volume":"13","author":"Marks","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2023.12.017_bib77","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41390-020-0940-4","article-title":"Genetic potential and height velocity during childhood and adolescence do not fully account for shorter stature in cystic fibrosis","volume":"89","author":"Zysman-Colman","year":"2021","journal-title":"Pediatr Res"},{"key":"10.1016\/j.clnu.2023.12.017_bib78","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1590\/1806-9282.64.11.1032","article-title":"The role of neonatal screening in nutritional evolution in the first 12 months after diagnosis of cystic fibrosis","volume":"64","author":"Martins","year":"2018","journal-title":"Rev Assoc Med Bras"},{"key":"10.1016\/j.clnu.2023.12.017_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2023.112091","article-title":"Dietary intake, weight status, pulmonary function and metabolic profile in children with cystic fibrosis with or without pancreatic sufficiency","author":"Papachristou","year":"2023","journal-title":"Nutrition"},{"key":"10.1016\/j.clnu.2023.12.017_bib80","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.0740","article-title":"Association of body mass index with clinical outcomes in patients with cystic fibrosis: a systematic review and meta-analysis","volume":"5","author":"Nagy","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clnu.2023.12.017_bib81","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/ped.12214","article-title":"Prevalence of malnutrition and obesity among cystic fibrosis patients","volume":"56","author":"Panagopoulou","year":"2014","journal-title":"Pediatr Int"},{"key":"10.1016\/j.clnu.2023.12.017_bib82","doi-asserted-by":"crossref","first-page":"11467","DOI":"10.3748\/wjg.v20.i33.11467","article-title":"Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century","volume":"20","author":"Trang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clnu.2023.12.017_bib83","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S1569-1993(02)00096-6","article-title":"Fecal elastase-1 cut-off levels in the assessment of exocrine pancreatic function in cystic fibrosis","volume":"1","author":"Walkowiak","year":"2002","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib84","first-page":"230","article-title":"Phase 3 comparison of higher-dose liprotamase, a nonporcine pancreatic enzyme replacement therapy, to pancrelipase on fat and protein absorption in subjects with exocrine pancreatic insufficiency due to cystic fibrosis","volume":"53","author":"Konstan","year":"2018","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.clnu.2023.12.017_bib85","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/MPG.0000000000000498","article-title":"Long-term experience with ZENPEP in infants with exocrine pancreatic insufficiency associated with cystic fibrosis","volume":"59","author":"Wooldridge","year":"2014","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib86","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jpeds.2014.01.022","article-title":"Pancreatic enzyme replacement therapy dosing and nutritional outcomes in children with cystic fibrosis","volume":"164","author":"Haupt","year":"2014","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2023.12.017_bib87","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1021\/mp4006529","article-title":"Characterization of a novel cross-linked lipase: impact of cross-linking on solubility and release from drug product","volume":"11","author":"Hetrick","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1016\/j.clnu.2023.12.017_bib88","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/MPG.0000000000000784","article-title":"Pancreatic enzyme replacement therapy and coefficient of fat absorption in children and adolescents with cystic fibrosis","volume":"61","author":"Woestenenk","year":"2015","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib89","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcf.2014.07.006","article-title":"Safety and efficacy of Creon\u00ae micro in children with exocrine pancreatic insufficiency due to cystic fibrosis","volume":"14","author":"Kashirskaya","year":"2015","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib90","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.3748\/wjg.v25.i20.2430","article-title":"Contribution of pancreatic enzyme replacement therapy to survival and quality of life in patients with pancreatic exocrine insufficiency","volume":"25","author":"Layer","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clnu.2023.12.017_bib91","article-title":"Timing of pancreatic enzyme replacement therapy (PERT) in cystic fibrosis","volume":"8","author":"Ng","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2023.12.017_bib92","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41390-020-0860-3","article-title":"Association between faecal pH and fat absorption in children with cystic fibrosis on a controlled diet and enzyme supplements dose","volume":"89","author":"Calvo-Lerma","year":"2021","journal-title":"Pediatr Res"},{"key":"10.1016\/j.clnu.2023.12.017_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2020.109198","article-title":"Lessons learnt from MyCyFAPP Project: effect of cystic fibrosis factors and inherent-to-food properties on lipid digestion in foods","volume":"133","author":"Calvo-Lerma","year":"2020","journal-title":"Food Res Int"},{"key":"10.1016\/j.clnu.2023.12.017_bib94","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.jcf.2020.11.016","article-title":"Clinical evaluation of an evidence-based method based on food characteristics to adjust pancreatic enzyme supplements dose in cystic fibrosis","volume":"20","author":"Calvo-Lerma","year":"2021","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib95","article-title":"Pancreatic enzyme replacement therapy for people with cystic fibrosis","volume":"8","author":"Somaraju","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2023.12.017_bib96","article-title":"Drug therapies for reducing gastric acidity in people with cystic fibrosis","volume":"4","author":"Ng","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2023.12.017_bib97","first-page":"44","article-title":"A\u00a0systematic Cochrane Review of the timing of pancreatic enzyme replacement therapy (PERT) in cystic fibrosis","volume":"40","author":"Ng","year":"2021","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.clnu.2023.12.017_bib98","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/MPG.0000000000003063","article-title":"Drugs in focus: proton pump inhibitors","volume":"72","author":"Orel","year":"2021","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib99","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.dld.2022.09.005","article-title":"Effects of prolonged proton pump inhibitor treatment on nutritional status and respiratory infection risk in cystic fibrosis: a matched cohort study","volume":"55","author":"Zazzeron","year":"2022","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clnu.2023.12.017_bib100","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jcf.2016.02.010","article-title":"Comparison of two pancreatic enzyme products for exocrine insufficiency in patients with cystic fibrosis","volume":"15","author":"Taylor","year":"2016","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib101","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/MPG.0000000000002108","article-title":"Relationship of initial pancreatic enzyme replacement therapy dose with weight gain in infants with cystic fibrosis","volume":"67","author":"Schechter","year":"2018","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib102","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jcf.2017.03.005","article-title":"Nutritional status, nutrient intake and use of enzyme supplements in paediatric patients with Cystic Fibrosis; a European multicentre study with reference to current guidelines","volume":"16","author":"Calvo-Lerma","year":"2017","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib103","article-title":"Clinical validation of an evidence-based method to adjust Pancreatic Enzyme Replacement Therapy through a prospective interventional study in paediatric patients with Cystic Fibrosis","volume":"14","author":"Calvo-Lerma","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.clnu.2023.12.017_bib104","article-title":"A\u00a0first approach for an evidence-based in\u00a0vitro digestion method to adjust pancreatic enzyme replacement therapy in cystic fibrosis","volume":"14","author":"Calvo-Lerma","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.clnu.2023.12.017_bib105","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/MPG.0000000000001829","article-title":"Pancreatic enzyme replacement therapy use in infants with cystic fibrosis diagnosed by newborn screening","volume":"66","author":"Gelfond","year":"2018","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib106","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1097\/MPA.0000000000000214","article-title":"Dependence of PERT endpoint on endogenous lipase activity","volume":"43","author":"Gao","year":"2014","journal-title":"Pancreas"},{"key":"10.1016\/j.clnu.2023.12.017_bib107","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jpeds.2016.05.049","article-title":"Safety and efficacy of a novel microbial lipase in patients with exocrine pancreatic insufficiency due to cystic fibrosis: a randomized controlled clinical trial","volume":"176","author":"Heubi","year":"2016","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2023.12.017_bib108","doi-asserted-by":"crossref","first-page":"684","DOI":"10.17235\/reed.2017.4951\/2017","article-title":"Pancreatic enzyme replacement therapy in cystic fibrosis: dose, variability and coefficient of fat absorption","volume":"109","author":"Calvo-Lerma","year":"2017","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.clnu.2023.12.017_bib109","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.pan.2015.07.001","article-title":"Clinical, anthropometric and laboratory nutritional markers of pancreatic exocrine insufficiency: prevalence and diagnostic use","volume":"15","author":"Lindkvist","year":"2015","journal-title":"Pancreatology"},{"key":"10.1016\/j.clnu.2023.12.017_bib110","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/jcph.484","article-title":"Malabsorption blood test: assessing fat absorption in patients with cystic fibrosis and pancreatic insufficiency","volume":"55","author":"Mascarenhas","year":"2015","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.clnu.2023.12.017_bib111","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3390\/biom11020313","article-title":"Severe genotype, pancreatic insufficiency and low dose of pancreatic enzymes associate with abnormal serum sterol profile in cystic fibrosis","volume":"11","author":"Drzymala-Czyz","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.clnu.2023.12.017_bib112","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/0884533614551838","article-title":"Nutrition and pancreatic enzyme intake in patients with cystic fibrosis with distal intestinal obstruction syndrome","volume":"30","author":"Declercq","year":"2015","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnu.2023.12.017_bib113","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1210\/jc.2013-4417","article-title":"Pancreatic enzyme supplementation improves the incretin hormone response and attenuates postprandial glycemia in adolescents with cystic fibrosis: a randomized crossover trial","volume":"99","author":"Perano","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnu.2023.12.017_bib114","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-2296","article-title":"Parental depression and pancreatic enzymes adherence in children with cystic fibrosis","volume":"137","author":"Barker","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.clnu.2023.12.017_bib115","doi-asserted-by":"crossref","DOI":"10.1177\/1479973119900612","article-title":"Hospitalization rates among patients with cystic fibrosis using pancreatic enzyme replacement therapy","volume":"17","author":"Trapnell","year":"2020","journal-title":"Chron Respir Dis"},{"key":"10.1016\/j.clnu.2023.12.017_bib116","doi-asserted-by":"crossref","DOI":"10.3390\/nu14071330","article-title":"Correlates of pancreatic enzyme replacement therapy intake in adults with cystic fibrosis: results of a cross-sectional study","volume":"14","author":"Olsen","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2023.12.017_bib117","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jcf.2016.03.008","article-title":"Preliminary report of the (13)C-mixed triglyceride breath test to assess timing of pancreatic enzyme replacement therapy in children with cystic fibrosis","volume":"15","author":"van der Haak","year":"2016","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib118","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/apa.16143","article-title":"Impact of timing of PERT on gastrointestinal symptoms in Danish children and adolescents with CF","volume":"111","author":"Raun","year":"2022","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.clnu.2023.12.017_bib119","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/MPG.0000000000002984","article-title":"Evaluation of the effectiveness of in-line immobilized lipase cartridge in enterally fed patients with cystic fibrosis","volume":"72","author":"Sathe","year":"2021","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib120","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/ncp.10831","article-title":"Improvements in anthropometric measures and gastrointestinal tolerance in patients with cystic fibrosis by using a digestive enzyme cartridge with overnight enteral nutrition","volume":"37","author":"Hendrix","year":"2022","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnu.2023.12.017_bib121","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/MPG.0000000000001617","article-title":"Increased fat absorption from enteral formula through an in-line digestive cartridge in patients with cystic fibrosis","volume":"65","author":"Freedman","year":"2017","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib122","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/MPG.0000000000002110","article-title":"Absorption and safety with sustained use of RELiZORB evaluation (ASSURE) study in patients with cystic fibrosis receiving enteral feeding","volume":"67","author":"Stevens","year":"2018","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib123","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bpg.2005.11.006","article-title":"Cystic fibrosis: nutritional consequences and management","volume":"20","author":"Dodge","year":"2006","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.clnu.2023.12.017_bib124","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1569-1993(02)00032-2","article-title":"Nutrition in patients with cystic fibrosis: a European Consensus","volume":"1","author":"Sinaasappel","year":"2002","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib125","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00394-002-0369-z","article-title":"Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway","volume":"41","author":"Dorl\u00f6chter","year":"2002","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib126","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/jclinpath-2013-201787","article-title":"Fat-soluble vitamin deficiency in children and adolescents with cystic fibrosis","volume":"67","author":"Rana","year":"2014","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.clnu.2023.12.017_bib127","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/MCP.0b013e3283136787","article-title":"Update on fat-soluble vitamins in cystic fibrosis","volume":"14","author":"Maqbool","year":"2008","journal-title":"Curr Opin Pulm Med"},{"issue":"Suppl 2","key":"10.1016\/j.clnu.2023.12.017_bib128","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.jcf.2019.08.022","article-title":"Vitamin D deficiency and its treatment in cystic fibrosis","volume":"18","author":"Daley","year":"2019","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib129","doi-asserted-by":"crossref","DOI":"10.3390\/nu13124413","article-title":"Vitamin D status in pediatric and young adult cystic fibrosis patients. Are the new recommendations effective?","volume":"13","author":"Mangas-S\u00e1nchez","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2023.12.017_bib130","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.3390\/nu13114048","article-title":"Vitamin D status and risk of cystic fibrosis-related diabetes: a retrospective single center cohort study","volume":"13","author":"Peng","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2023.12.017_bib131","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/j.gastro.2010.09.046","article-title":"Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis","volume":"140","author":"Ooi","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2023.12.017_bib132","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.14309\/ajg.0000000000001527","article-title":"Cystic fibrosis transmembrane conductance regulator modulator use is associated with reduced pancreatitis hospitalizations in patients with cystic fibrosis","volume":"116","author":"Ramsey","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clnu.2023.12.017_bib133","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S2213-2600(18)30202-9","article-title":"Ivacaftor treatment of cystic fibrosis in children aged 12 to< 24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study","volume":"6","author":"Rosenfeld","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.clnu.2023.12.017_bib134","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jcf.2019.03.009","article-title":"An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2\u20135 years (KLIMB)","volume":"18","author":"Rosenfeld","year":"2019","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2023.12.017_bib135","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1002\/ppul.25065","article-title":"Persistent recovery of pancreatic function in patients with cystic fibrosis after ivacaftor","volume":"55","author":"Munce","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.clnu.2023.12.017_bib136","series-title":"The Australian and New Zealand cystic fibrosis nutrition guideline authorship group. Nutrition guidelines for cystic fibrosis in Australia and New Zealand","author":"Saxby","year":"2017"},{"key":"10.1016\/j.clnu.2023.12.017_bib137","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jcf.2015.01.006","article-title":"Cystic fibrosis and the role of gastrointestinal outcome measures in the new era of therapeutic CFTR modulation","volume":"14","author":"Bodewes","year":"2015","journal-title":"J\u00a0Cyst Fibros\u202f: Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib138","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/MPG.0000000000002688","article-title":"Assessment and interpretation of vitamin and trace element status in sick children: a position paper from the European society for paediatric gastroenterology Hepatology, and nutrition committee on nutrition","volume":"70","author":"Gerasimidis","year":"2020","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib139","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.jand.2020.03.015","article-title":"Academy of nutrition and dietetics: 2020 cystic fibrosis evidence analysis center evidence-based nutrition practice guideline","volume":"121","author":"McDonald","year":"2021","journal-title":"J\u00a0Acad Nutr Diet"},{"key":"10.1016\/j.clnu.2023.12.017_bib140","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1513\/AnnalsATS.201306-171BC","article-title":"Vitamin D status in children with cystic fibrosis. Associations with inflammation and bacterial colonization","volume":"11","author":"Simoneau","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.clnu.2023.12.017_bib141","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jcf.2021.12.014","article-title":"Nutritional status and lung function in children with pancreatic-sufficient cystic fibrosis","volume":"21","author":"Madde","year":"2022","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib142","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1183\/09031936.00166412","article-title":"Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry","volume":"43","author":"Kerem","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.clnu.2023.12.017_bib143","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jcf.2020.04.008","article-title":"Average rate of lung function decline in adults with cystic fibrosis in the United Kingdom: data from the UK CF registry","volume":"20","author":"Caley","year":"2021","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib144","doi-asserted-by":"crossref","DOI":"10.3390\/nu14061216","article-title":"The changing landscape of nutrition in cystic fibrosis: the emergence of overweight and obesity","volume":"14","author":"Bailey","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2023.12.017_bib145","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jcf.2020.11.022","article-title":"Influence of pre-diabetic and pancreatic exocrine states on pulmonary and nutritional status in adults with Cystic Fibrosis","volume":"20","author":"Potter","year":"2021","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib146","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jcf.2021.06.010","article-title":"Preclinical atherosclerosis in cystic fibrosis: two distinct presentations are related to pancreatic status","volume":"21","author":"Nowak","year":"2022","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib147","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jpeds.2015.07.044","article-title":"Early life growth trajectories in cystic fibrosis are associated with pulmonary function at age 6 years","volume":"167","author":"Sanders","year":"2015","journal-title":"J\u00a0Pediatr"},{"issue":"3","key":"10.1016\/j.clnu.2023.12.017_bib148","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jcf.2022.09.001","article-title":"Trajectories of early growth and subsequent lung function in cystic fibrosis: an observational study using UK and Canadian registry data","volume":"22","author":"Macdougall","year":"2023","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2023.12.017_bib149","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jada.2008.02.020","article-title":"Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review","volume":"108","author":"Stallings","year":"2008","journal-title":"J\u00a0Am Diet Assoc"},{"key":"10.1016\/j.clnu.2023.12.017_bib150","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3945\/ajcn.112.051409","article-title":"Longitudinal trends in nutritional status and the relation between lung function and BMI in cystic fibrosis: a population-based cohort study","volume":"97","author":"Stephenson","year":"2013","journal-title":"Am J Clin Nutr"},{"issue":"Suppl 1","key":"10.1016\/j.clnu.2023.12.017_bib151","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jcf.2014.03.010","article-title":"European cystic fibrosis society standards of care: best practice guidelines","volume":"13","author":"Smyth","year":"2014","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib152","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jcf.2012.10.004","article-title":"Treatment of lung infection in patients with cystic fibrosis: current and future strategies","volume":"11","author":"D\u00f6ring","year":"2012","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib153","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The future of cystic fibrosis care: a global perspective","volume":"8","author":"Bell","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.clnu.2023.12.017_bib154","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/ijns6010018","article-title":"Newborn screening for CF across the globe-where is it worthwhile?","volume":"6","author":"Scotet","year":"2020","journal-title":"Int J Neonat Screen"},{"key":"10.1016\/j.clnu.2023.12.017_bib155","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/jamapediatrics.2017.0206","article-title":"Effects of diagnosis by newborn screening for cystic fibrosis on weight and length in the first year of life","volume":"171","author":"Leung","year":"2017","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.clnu.2023.12.017_bib156","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jpeds.2016.10.045","article-title":"Differences in outcomes between early and late diagnosis of cystic fibrosis in the newborn screening era","volume":"181","author":"Coffey","year":"2017","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2023.12.017_bib157","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcf.2021.08.005","article-title":"Impact of guideline-recommended dietitian assessments on weight gain in infants with cystic fibrosis","volume":"21","author":"Ong","year":"2022","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib158","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jcf.2022.05.003","article-title":"Association between stool consistency and clinical variables among infants with cystic fibrosis: findings from the BONUS study","volume":"21","author":"Freeman","year":"2022","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib159","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/MPG.0000000000003173","article-title":"Gastrointestinal factors associated with hospitalization in infants with cystic fibrosis: results from the baby observational and nutrition study","volume":"73","author":"Sathe","year":"2021","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib160","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1002\/ppul.24876","article-title":"Neonatal screening programme for CF: results from the Irish comparative outcomes study (ICOS)","volume":"55","author":"Fitzgerald","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.clnu.2023.12.017_bib161","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jpeds.2015.02.049","article-title":"Associations between gut microbial colonization in early life and respiratory outcomes in cystic fibrosis","volume":"167","author":"Hoen","year":"2015","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2023.12.017_bib162","doi-asserted-by":"crossref","DOI":"10.3390\/nu13093263","article-title":"Breastfeeding in cystic fibrosis: a systematic review on prevalence and potential benefits","volume":"13","author":"Colombo","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2023.12.017_bib163","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/MPG.0000000000002415","article-title":"Lactation consultation sustains breast milk intake in infants with cystic fibrosis","volume":"69","author":"Miller","year":"2019","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib164","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1089\/bfm.2018.29080.sdf","article-title":"Breast milk fats and lipids: expanding benefits to fragile infant populations","volume":"13","author":"Freedman","year":"2018","journal-title":"Breastfeed Med"},{"key":"10.1016\/j.clnu.2023.12.017_bib165","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1089\/bfm.2019.0038","article-title":"Supporting optimal growth in infants with chronic conditions: how are we doing and what can we do?","volume":"14","author":"Smith","year":"2019","journal-title":"Breastfeed Med"},{"key":"10.1016\/j.clnu.2023.12.017_bib166","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.jand.2020.05.011","article-title":"Sodium status and replacement in children and adults living with cystic fibrosis: a narrative review","volume":"120","author":"Declercq","year":"2020","journal-title":"J\u00a0Acad Nutr Diet"},{"key":"10.1016\/j.clnu.2023.12.017_bib167","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/MPG.0000000000001454","article-title":"Complementary feeding: a position paper by the European society for paediatric gastroenterology, Hepatology, and nutrition (ESPGHAN) committee on nutrition","volume":"64","author":"Fewtrell","year":"2017","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib168","doi-asserted-by":"crossref","first-page":"141","DOI":"10.23736\/S0026-4806.19.06320-1","article-title":"Complementary feeding: new styles versus old myths","volume":"111","author":"Dipasquale","year":"2020","journal-title":"Minerva Med"},{"key":"10.1016\/j.clnu.2023.12.017_bib169","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s13668-017-0201-2","article-title":"Baby-Led weaning: the evidence to date","volume":"6","author":"Brown","year":"2017","journal-title":"Curr Nutr Rep"},{"key":"10.1016\/j.clnu.2023.12.017_bib170","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13052-018-0487-8","article-title":"Baby-led weaning: what a systematic review of the literature adds on","volume":"44","author":"D'Auria","year":"2018","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.clnu.2023.12.017_bib171","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jcf.2019.09.008","article-title":"Differences in clinical outcomes of paediatric cystic fibrosis patients with and without meconium ileus","volume":"18","author":"Tan","year":"2019","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"issue":"Suppl 2","key":"10.1016\/j.clnu.2023.12.017_bib172","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jcf.2017.06.007","article-title":"Meconium ileus in cystic fibrosis","volume":"16","author":"Sathe","year":"2017","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib173","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jcf.2019.07.003","article-title":"Risk factors for adverse outcome in infancy in meconium ileus cystic fibrosis infants: a multicentre Italian study","volume":"18","author":"Padoan","year":"2019","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib174","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.jpedsurg.2018.05.016","article-title":"Predictors for surgical intervention and surgical outcomes in neonates with cystic fibrosis","volume":"53","author":"Jessula","year":"2018","journal-title":"J\u00a0Pediatr Surg"},{"key":"10.1016\/j.clnu.2023.12.017_bib175","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jpedsurg.2021.02.047","article-title":"Early management of meconium ileus in infants with cystic fibrosis: a prospective population cohort study","volume":"56","author":"Long","year":"2021","journal-title":"J\u00a0Pediatr Surg"},{"key":"10.1016\/j.clnu.2023.12.017_bib176","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jcf.2005.05.015","article-title":"Mealtime behaviors in families of infants and toddlers with cystic fibrosis","volume":"4","author":"Powers","year":"2005","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib177","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1017\/S0029665109990176","article-title":"Symposium 6: young people, artificial nutrition and transitional care. The nutritional challenges of the young adult with cystic fibrosis: transition","volume":"68","author":"Morton","year":"2009","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.clnu.2023.12.017_bib178","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jcf.2013.11.001","article-title":"Recurrent pulmonary exacerbations are associated with low fat free mass and low bone mineral density in young adults with cystic fibrosis","volume":"13","author":"Alicandro","year":"2014","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib179","first-page":"337","article-title":"Factors associated with malnutrition in adolescent and adult patients with cystic fibrosis","volume":"43","author":"Barni","year":"2017","journal-title":"J\u00a0Bras Pneumol"},{"key":"10.1016\/j.clnu.2023.12.017_bib180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122705","article-title":"Multidimensional clinical phenotyping of an adult cystic fibrosis patient population","volume":"10","author":"Conrad","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.clnu.2023.12.017_bib181","doi-asserted-by":"crossref","DOI":"10.1186\/s40795-018-0266-3","article-title":"A\u00a0survey identifying nutritional needs in a contemporary adult cystic fibrosis cohort","volume":"5","author":"Kapnadak","year":"2019","journal-title":"BMC Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib182","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1177\/0148607115617152","article-title":"Characteristics of resting metabolic rate in critically Ill, mechanically ventilated adults with cystic fibrosis","volume":"41","author":"Frankenfield","year":"2017","journal-title":"J\u00a0Parenter Enter Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib183","first-page":"4","article-title":"Nutritional management of cystic fibrosis - an update for the 21st century","volume":"26","author":"Collins","year":"2018","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.clnu.2023.12.017_bib184","first-page":"42","article-title":"Cystic fibrosis nutrition--chewing the fat","volume":"17","author":"Connett","year":"2016","journal-title":"Paediatr Respir Rev"},{"issue":"3","key":"10.1016\/j.clnu.2023.12.017_bib185","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jcf.2021.07.019","article-title":"Pregnancy in cystic fibrosis: review of the literature and expert recommendations","volume":"21","author":"Jain","year":"2022","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2023.12.017_bib186","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1753495X14554022","article-title":"Pregnancy and cystic fibrosis: approach to contemporary management","volume":"7","author":"Geake","year":"2014","journal-title":"Obstet Med"},{"key":"10.1016\/j.clnu.2023.12.017_bib187","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jcf.2019.06.003","article-title":"Pregnancy outcome in women with cystic fibrosis and poor pulmonary function","volume":"19","author":"Reynaud","year":"2020","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib188","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1126\/science.abe5017","article-title":"Daily energy expenditure through the human life course","volume":"373","author":"Pontzer","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.clnu.2023.12.017_bib189","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ccm.2015.11.009","article-title":"Nutritional issues in cystic fibrosis","volume":"37","author":"Solomon","year":"2016","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.clnu.2023.12.017_bib190","first-page":"661","article-title":"Nutrition and growth in cystic fibrosis","volume":"63","author":"Lusman","year":"2016","journal-title":"Pediatr Clin"},{"key":"10.1016\/j.clnu.2023.12.017_bib191","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ppul.23128","article-title":"Improving nutritional status in a pediatric cystic fibrosis center","volume":"50","author":"Ramirez","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.clnu.2023.12.017_bib192","article-title":"Oral calorie supplements for cystic fibrosis","volume":"5","author":"Smyth","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2023.12.017_bib193","first-page":"1","article-title":"Oral nutritional supplements in adults with cystic fibrosis: effects on intake, levels of fat-soluble vitamins, and bone remodeling biomarkers","volume":"13","author":"Victoria","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2023.12.017_bib194","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/ncp.10605","article-title":"Variations in nutrition practices in cystic fibrosis: a survey of the digest Program","volume":"36","author":"Shaikhkhalil","year":"2021","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnu.2023.12.017_bib195","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jcf.2013.08.009","article-title":"Effects of nutritional status and dietetic interventions on survival in Cystic Fibrosis patients before and after lung transplantation","volume":"13","author":"Hollander","year":"2014","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib196","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jcf.2018.01.004","article-title":"The effect of enteral tube feeding in cystic fibrosis: a registry based study","volume":"17","author":"Libeert","year":"2018","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib197","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41430-020-00782-5","article-title":"Long-term use of tube feeding in children with cystic fibrosis: results from two Belgian CF centers","volume":"75","author":"Declercq","year":"2021","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib198","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.jand.2017.07.006","article-title":"Body weight and body mass index in patients with end-stage cystic fibrosis stabilize after the start of enteral tube feeding","volume":"117","author":"Hollander","year":"2017","journal-title":"J\u00a0Acad Nutr Diet"},{"key":"10.1016\/j.clnu.2023.12.017_bib199","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/jpc.12888","article-title":"Clinical audit results in earlier nutritional intervention in malnourished children with cystic fibrosis with improved outcome","volume":"51","author":"Ledder","year":"2015","journal-title":"J\u00a0Paediatr Child Health"},{"key":"10.1016\/j.clnu.2023.12.017_bib200","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/ncp.10219","article-title":"Percutaneous endoscopic gastrostomy tubes may Be associated with preservation of lung function in patients with cystic fibrosis","volume":"34","author":"Khalaf","year":"2019","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnu.2023.12.017_bib201","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jcf.2016.08.004","article-title":"Enteral tube feeding for individuals with cystic fibrosis: cystic Fibrosis Foundation evidence-informed guidelines","volume":"15","author":"Schwarzenberg","year":"2016","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib202","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/jpen.1676","article-title":"Long-term parenteral nutrition in a patient with cystic fibrosis during pregnancy","volume":"43","author":"Mulherin","year":"2019","journal-title":"J\u00a0Parenter Enter Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib203","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-233346","article-title":"Intradialytic parenteral nutrition improves nutritional status in a complex cystic fibrosis patient with redo double lung transplant and end-stage renal disease","volume":"13","author":"Melville","year":"2020","journal-title":"BMJ Case Rep"},{"issue":"Suppl 2","key":"10.1016\/j.clnu.2023.12.017_bib204","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S1569-1993(11)60004-0","article-title":"European cystic fibrosis bone mineralisation guidelines","volume":"10","author":"Sermet-Gaudelus","year":"2011","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib205","doi-asserted-by":"crossref","DOI":"10.3402\/fnr.v55i0.7561","article-title":"Dietary intake and nutritional status in a Scandinavian adult cystic fibrosis-population compared with recommendations","volume":"55","author":"Moen","year":"2011","journal-title":"Food Nutr Res"},{"key":"10.1016\/j.clnu.2023.12.017_bib206","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.jada.2007.09.005","article-title":"Nutrient status of adults with cystic fibrosis","volume":"107","author":"Gordon","year":"2007","journal-title":"J\u00a0Am Diet Assoc"},{"key":"10.1016\/j.clnu.2023.12.017_bib207","doi-asserted-by":"crossref","DOI":"10.3390\/nu12103126","article-title":"Adherence to dietary recommendations, nutrient intake adequacy and diet quality among pediatric cystic fibrosis patients: results from the GreeCF study","volume":"12","author":"Poulimeneas","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2023.12.017_bib208","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.advms.2015.05.002","article-title":"Evaluation of factors related to bone disease in Polish children and adolescents with cystic fibrosis","volume":"60","author":"Sands","year":"2015","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.clnu.2023.12.017_bib209","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jcf.2004.08.002","article-title":"Randomised double blind placebo controlled trial investigating the effect of calcium and vitamin D supplementation on bone mineral density and bone metabolism in adult patients with cystic fibrosis","volume":"3","author":"Haworth","year":"2004","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib210","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ppul.20863","article-title":"Percent true calcium absorption, mineral metabolism, and bone mineralization in children with cystic fibrosis: effect of supplementation with vitamin D and calcium","volume":"43","author":"Hillman","year":"2008","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.clnu.2023.12.017_bib211","doi-asserted-by":"crossref","DOI":"10.3390\/nu11010150","article-title":"Zinc nutritional status in patients with cystic fibrosis","volume":"11","author":"Escobedo Monge","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2023.12.017_bib212","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1002\/ppul.25666","article-title":"Zinc status and growth in infants and young children with cystic fibrosis","volume":"56","author":"Bauer","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.clnu.2023.12.017_bib213","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jtemb.2013.10.003","article-title":"Plasma zinc in adults with cystic fibrosis: correlations with clinical outcomes","volume":"28","author":"Damphousse","year":"2014","journal-title":"J\u00a0Trace Elem Med Biol"},{"key":"10.1016\/j.clnu.2023.12.017_bib214","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/ncp.10899","article-title":"Update on the management of vitamins and minerals in cystic fibrosis","volume":"37","author":"Sankararaman","year":"2022","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnu.2023.12.017_bib215","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jand.2020.01.007","article-title":"Antioxidant micronutrients and essential fatty acids supplementation on cystic fibrosis outcomes: a systematic review","volume":"120","author":"Simon","year":"2020","journal-title":"J\u00a0Acad Nutr Diet"},{"key":"10.1016\/j.clnu.2023.12.017_bib216","article-title":"Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis","volume":"7","author":"Hurley","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2023.12.017_bib217","first-page":"127","article-title":"Effect of supplementary zinc on body mass index, pulmonary function and hospitalization in children with cystic fibrosis","volume":"56","author":"Ataee","year":"2014","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.clnu.2023.12.017_bib218","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4187\/respcare.04038","article-title":"Zinc supplementation for one year among children with cystic fibrosis does not decrease pulmonary infection","volume":"61","author":"Sharma","year":"2016","journal-title":"Respir Care"},{"key":"10.1016\/j.clnu.2023.12.017_bib219","first-page":"28","article-title":"A\u00a0systematic Cochrane Review of antioxidant supplementation lung disease for cystic fibrosis","volume":"33","author":"Ciofu","year":"2020","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.clnu.2023.12.017_bib220","series-title":"Selenium. StatPearls. Treasure Island (FL): StatPearls Publishing copyright \u00a9 2022","author":"Nessel","year":"2022"},{"key":"10.1016\/j.clnu.2023.12.017_bib221","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1164\/rccm.201801-0105OC","article-title":"Effects of an antioxidant-enriched multivitamin in cystic fibrosis. A randomized, controlled, multicenter clinical trial","volume":"198","author":"Sagel","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clnu.2023.12.017_bib222","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/ajcn\/77.1.150","article-title":"Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function","volume":"77","author":"Wood","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib223","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ppul.22857","article-title":"Iron deficiency occurs frequently in children with cystic fibrosis","volume":"49","author":"Uijterschout","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.clnu.2023.12.017_bib224","first-page":"1101","article-title":"Prevalence and risk factors for iron deficiency in adults with cystic fibrosis","volume":"vol. 35","author":"Gettle","year":"2020"},{"key":"10.1016\/j.clnu.2023.12.017_bib225","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/0884533608323426","article-title":"Anemia in cystic fibrosis: incidence, mechanisms, and association with pulmonary function and vitamin deficiency","volume":"23","author":"von Drygalski","year":"2008","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnu.2023.12.017_bib226","first-page":"386","article-title":"Changes in micronutrient status during and after pulmonary exacerbation in adult cystic fibrosis","volume":"63","author":"Lee","year":"2015","journal-title":"J\u00a0Invest Med"},{"key":"10.1016\/j.clnu.2023.12.017_bib227","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1378\/chest.121.1.48","article-title":"Iron deficiency in cystic fibrosis: relationship to lung disease severity and chronic Pseudomonas aeruginosa infection","volume":"121","author":"Reid","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.clnu.2023.12.017_bib228","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jcf.2013.11.004","article-title":"Iron supplementation does not worsen respiratory health or alter the sputum microbiome in cystic fibrosis","volume":"13","author":"Gifford","year":"2014","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2023.12.017_bib229","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cca.2006.11.021","article-title":"The use of soluble transferrin receptor to assess iron deficiency in adults with cystic fibrosis","volume":"378","author":"Khalid","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clnu.2023.12.017_bib230","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jcf.2014.03.007","article-title":"The value of soluble transferrin receptor and hepcidin in the assessment of iron status in children with cystic fibrosis","volume":"13","author":"Uijterschout","year":"2014","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib231","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"Weiss","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnu.2023.12.017_bib232","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1542\/peds.12.5.549","article-title":"Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas; clinical significance and relationship to the disease","volume":"12","author":"Di Sant'Agnese","year":"1953","journal-title":"Pediatrics"},{"key":"10.1016\/j.clnu.2023.12.017_bib233","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00467-013-2712-4","article-title":"Electrolyte abnormalities in cystic fibrosis: systematic review of the literature","volume":"29","author":"Scurati-Manzoni","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.clnu.2023.12.017_bib234","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jcf.2009.08.006","article-title":"Evaluation of salt supplementation in CF infants","volume":"8","author":"Coates","year":"2009","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib235","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/BF01972892","article-title":"Sodium chloride deficiency in cystic fibrosis patients","volume":"153","author":"Ozcelik","year":"1994","journal-title":"Eur J Pediatr"},{"issue":"2","key":"10.1016\/j.clnu.2023.12.017_bib236","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1016\/j.jcf.2021.11.002","article-title":"Urinary sodium\/creatinine ratio is a predictor for fractional sodium excretion and related to age in patients with cystic fibrosis","volume":"21","author":"Declercq","year":"2022","journal-title":"J\u00a0Cyst Fibros2022"},{"key":"10.1016\/j.clnu.2023.12.017_bib237","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jcf.2010.04.008","article-title":"Guidelines on the early management of infants diagnosed with cystic fibrosis following newborn screening","volume":"9","author":"Sermet-Gaudelus","year":"2010","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib238","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jpeds.2009.09.001","article-title":"Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis","volume":"155","author":"Borowitz","year":"2009","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2023.12.017_bib239","series-title":"Nutritional management of cystic fibrosis","year":"2016"},{"key":"10.1016\/j.clnu.2023.12.017_bib240","first-page":"CD002201","article-title":"Omega-3 fatty acids for cystic fibrosis","volume":"2016","author":"Oliver","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2023.12.017_bib241","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2020.102156","article-title":"Abnormal n-6 fatty acid metabolism in cystic fibrosis contributes to pulmonary symptoms","volume":"160","author":"Wheelock","year":"2020","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.clnu.2023.12.017_bib242","doi-asserted-by":"crossref","DOI":"10.3390\/nu14040853","article-title":"Nutrition in cystic fibrosis-some notes on the fat recommendations","volume":"14","author":"Strandvik","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2023.12.017_bib243","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008190.pub2","article-title":"Appetite stimulants for people with cystic fibrosis","author":"Chinuck","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2023.12.017_bib244","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.clnesp.2021.01.015","article-title":"Cyproheptadine as an appetite stimulant in children with cystic fibrosis","volume":"42","author":"Grunert","year":"2021","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.clnu.2023.12.017_bib245","article-title":"Appetite stimulants for people with cystic fibrosis","volume":"9","author":"McTavish","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2023.12.017_bib246","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00774-014-0572-z","article-title":"Factors associated with low bone mineral density in patients with cystic fibrosis","volume":"33","author":"Sheikh","year":"2015","journal-title":"J\u00a0Bone Miner Metabol"},{"key":"10.1016\/j.clnu.2023.12.017_bib247","first-page":"151","article-title":"Prevalence of low bone mass and vitamin D deficiency in pediatric and adult patients with cystic fibrosis in Republic of Macedonia","volume":"35","author":"Jakovska","year":"2014","journal-title":"Pril (Makedon Akad Nauk Umet Odd Med Nauki)"},{"key":"10.1016\/j.clnu.2023.12.017_bib248","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/MCP.0000000000000624","article-title":"Prevention of osteoporosis in cystic fibrosis","volume":"25","author":"Chedevergne","year":"2019","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.clnu.2023.12.017_bib249","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1007\/s00198-017-4179-9","article-title":"Children and adolescents with cystic fibrosis display moderate bone microarchitecture abnormalities: data from high-resolution peripheral quantitative computed tomography","volume":"28","author":"Braun","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.clnu.2023.12.017_bib250","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1007\/s00198-016-3612-9","article-title":"Reduced bone volumetric density and weak correlation between infection and bone markers in cystic fibrosis adult patients","volume":"27","author":"Gensburger","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.clnu.2023.12.017_bib251","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jbspin.2015.04.021","article-title":"Body composition, lung function, and prevalent and progressive bone deficits among adults with cystic fibrosis","volume":"83","author":"Baker","year":"2016","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.clnu.2023.12.017_bib252","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jcf.2016.06.004","article-title":"Multiple prevalent fractures in relation to macroscopic bone architecture in patients with cystic fibrosis","volume":"17","author":"Stahl","year":"2018","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib253","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bone.2017.11.006","article-title":"Adults with cystic fibrosis have deficits in bone structure and strength at the distal tibia despite similar size and measuring standard and relative sites","volume":"107","author":"Nishiyama","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.clnu.2023.12.017_bib254","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bone.2017.02.007","article-title":"Impaired rib bone mass and quality in end-stage cystic fibrosis patients","volume":"98","author":"Mailhot","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.clnu.2023.12.017_bib255","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.7754\/Clin.Lab.2016.160141","article-title":"Genetic expression in cystic fibrosis related bone disease. An observational, transversal, cross-sectional study","volume":"62","author":"Ciuca","year":"2016","journal-title":"Clin Lab"},{"key":"10.1016\/j.clnu.2023.12.017_bib256","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1515\/jpem-2016-0057","article-title":"A\u00a0retrospective analysis of longitudinal changes in bone mineral content in cystic fibrosis","volume":"30","author":"Chirita-Emandi","year":"2017","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.clnu.2023.12.017_bib257","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/CPT.0000000000000016","article-title":"Exercise and habitual physical activity for people with cystic fibrosis: expert consensus, evidence-based guide for advising patients","volume":"26","author":"Swisher","year":"2015","journal-title":"Cardiopulm Phys Ther J"},{"key":"10.1016\/j.clnu.2023.12.017_bib258","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1590\/bjpt-rbf.2014.0154","article-title":"The role of daily physical activity and nutritional status on bone turnover in cystic fibrosis: a cross-sectional study","volume":"20","author":"Tejero","year":"2016","journal-title":"Braz J Phys Ther"},{"key":"10.1016\/j.clnu.2023.12.017_bib259","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s12098-019-03019-x","article-title":"Effects of exercise intervention Program on bone mineral accretion in children and adolescents with cystic fibrosis: a randomized controlled trial","volume":"86","author":"Gupta","year":"2019","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.clnu.2023.12.017_bib260","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1002\/ppul.25375","article-title":"The clinical features that contribute to poor bone health in young Australians living with cystic fibrosis: a recommendation for BMD screening","volume":"56","author":"Atlas","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.clnu.2023.12.017_bib261","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1002\/ppul.24925","article-title":"Understanding the interplay between factors that influence bone mineral density in CF","volume":"55","author":"Gur","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.clnu.2023.12.017_bib262","article-title":"Evaluation of bone disease in patients with cystic fibrosis and end-stage lung disease","volume":"45","author":"Robinson","year":"2019","journal-title":"J\u00a0Bras Pneumol"},{"key":"10.1016\/j.clnu.2023.12.017_bib263","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jocd.2019.02.003","article-title":"Celiac disease and bone health in children and adolescents: a systematic review and meta-analysis","volume":"23","author":"Fedewa","year":"2020","journal-title":"J\u00a0Clin Densitom"},{"key":"10.1016\/j.clnu.2023.12.017_bib264","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1007\/s00431-021-04011-4","article-title":"Does cystic fibrosis make susceptible to celiac disease?","volume":"180","author":"Emiralioglu","year":"2021","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.clnu.2023.12.017_bib265","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00431-017-2906-z","article-title":"Body composition and lung function in children with cystic fibrosis and meconium ileus","volume":"176","author":"Doulgeraki","year":"2017","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.clnu.2023.12.017_bib266","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jcf.2021.04.004","article-title":"The prevalence of aberrations in body composition in pediatric cystic fibrosis patients and relationships with pulmonary function, bone mineral density, and hospitalizations","volume":"20","author":"Ritchie","year":"2021","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib267","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.clnesp.2021.08.020","article-title":"Evaluation of anthropometry as an alternative to DXA as predictor of low bone mineral density in children and adolescents with cystic fibrosis","volume":"45","author":"Silva Junior","year":"2021","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.clnu.2023.12.017_bib268","first-page":"5237","article-title":"Low bone mineral density and associated factors in patients with cystic fibrosis: a cross-sectional study","volume":"5","author":"Nodoushan","year":"2017","journal-title":"Int J Pediatr"},{"key":"10.1016\/j.clnu.2023.12.017_bib269","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00198-019-04893-z","article-title":"Bone involvement in young adults with cystic fibrosis awaiting lung transplantation for end-stage respiratory failure","volume":"30","author":"Cairoli","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.clnu.2023.12.017_bib270","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.clnu.2013.12.008","article-title":"Increased whole body hydroxyproline production as assessed by a new stable isotope technique is associated with hip and spine bone mineral loss in cystic fibrosis","volume":"33","author":"Engelen","year":"2014","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib271","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jpeds.2019.07.073","article-title":"Bone health in children and youth with cystic fibrosis: a systematic review and meta-analysis of matched cohort studies","volume":"215","author":"Ubago-Guisado","year":"2019","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2023.12.017_bib272","first-page":"79","article-title":"Assessing bone mineral density in Italian adult cystic fibrosis patients: a cross sectional study","volume":"29","author":"Solarino","year":"2015","journal-title":"J\u00a0Biol Regul Homeost Agents"},{"issue":"Suppl 2","key":"10.1016\/j.clnu.2023.12.017_bib273","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/j.jcf.2019.08.017","article-title":"Cystic fibrosis bone disease treatment: current knowledge and future directions","volume":"18","author":"Putman","year":"2019","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib274","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jocd.2014.01.003","article-title":"Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD Pediatric Official Positions","volume":"17","author":"Crabtree","year":"2014","journal-title":"J\u00a0Clin Densitom"},{"key":"10.1016\/j.clnu.2023.12.017_bib275","first-page":"138","article-title":"Bone densitometry in children and adolescents","author":"Bachrach","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.clnu.2023.12.017_bib276","article-title":"Celiac disease in patients with cystic fibrosis-related bone disease","volume":"2017","author":"Putman","year":"2017","journal-title":"Case Rep Endocrinol"},{"issue":"Suppl 2","key":"10.1016\/j.clnu.2023.12.017_bib277","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.jcf.2019.08.018","article-title":"Cystic fibrosis bone disease: pathophysiology, assessment and prognostic implications","volume":"18","author":"Anabtawi","year":"2019","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib278","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jcf.2015.04.005","article-title":"Cystic fibrosis-related bone disease in children: examination of peripheral quantitative computed tomography (pQCT) data","volume":"14","author":"Brookes","year":"2015","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib279","article-title":"Treatment of cystic fibrosis related bone disease","volume":"27","author":"Ullal","year":"2022","journal-title":"J\u00a0Clin Transl Endocrinol"},{"key":"10.1016\/j.clnu.2023.12.017_bib280","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.79002","article-title":"The effect of calcium supplementation in people under 35 years old: a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Liu","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.clnu.2023.12.017_bib281","first-page":"CD002010","article-title":"Bisphosphonates for osteoporosis in people with cystic fibrosis","volume":"1","author":"Jeffery","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2023.12.017_bib282","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1016\/j.jcf.2021.07.013","article-title":"Impact of bone-active drugs and underlying disease on bone health after lung transplantation: a longitudinal study","volume":"20","author":"Grassi","year":"2021","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib283","first-page":"CD002010","article-title":"Bisphosphonates for osteoporosis in people with cystic fibrosis","volume":"2014","author":"Conwell","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2023.12.017_bib284","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.amjms.2020.06.005","article-title":"Relationship between estrogen treatment and skeletal health in women with cystic fibrosis","volume":"360","author":"Wu","year":"2020","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.clnu.2023.12.017_bib285","article-title":"Oral ethinyl estradiol treatment in women with cystic fibrosis is associated with lower bone mineral density","volume":"20","author":"Wu","year":"2020","journal-title":"J\u00a0Clin Transl Endocrinol"},{"key":"10.1016\/j.clnu.2023.12.017_bib286","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1210\/jc.2015-1512","article-title":"Age- and sex-dependent distribution of OGTT-related variables in a population of cystic fibrosis patients","volume":"100","author":"Battezzati","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnu.2023.12.017_bib287","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcf.2019.10.009","article-title":"Cystic fibrosis related diabetes in Europe: prevalence, risk factors and outcome; Olesen et\u00a0al","volume":"19","author":"Olesen","year":"2020","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib288","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1515\/jpem-2019-0484","article-title":"Cystic fibrosis-related diabetes: an update on pathophysiology, diagnosis, and treatment","volume":"33","author":"Alves","year":"2020","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.clnu.2023.12.017_bib289","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.673539","article-title":"Diabetes and prediabetes in children with cystic fibrosis: a systematic review of the literature and recommendations of the Italian society for pediatric endocrinology and diabetes (ISPED)","volume":"12","author":"Mozzillo","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.clnu.2023.12.017_bib290","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jcf.2019.04.015","article-title":"Incidence and risk factors of paediatric cystic fibrosis-related diabetes","volume":"18","author":"Perrem","year":"2019","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib291","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jcf.2019.05.005","article-title":"Peak OGTT glucose is associated with lower lung function in young children with cystic fibrosis","volume":"19","author":"Prentice","year":"2020","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib292","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jcf.2013.11.005","article-title":"Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients","volume":"13","author":"Leclercq","year":"2014","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib293","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1002\/ppul.25572","article-title":"Nutritional status between 5-10 years is associated with cystic fibrosis-related diabetes in adolescence","volume":"56","author":"Ararat","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.clnu.2023.12.017_bib294","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00592-015-0791-3","article-title":"The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis","volume":"53","author":"Coriati","year":"2016","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.clnu.2023.12.017_bib295","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jcf.2017.01.018","article-title":"Association between glucose intolerance and bacterial colonisation in an adult population with cystic fibrosis, emergence of Stenotrophomonas maltophilia","volume":"16","author":"Lehoux Dubois","year":"2017","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib296","doi-asserted-by":"crossref","first-page":"4763","DOI":"10.1038\/s41598-019-40592-9","article-title":"Glucose tolerance in Canadian and French cystic fibrosis adult patients","volume":"9","author":"Reynaud","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.clnu.2023.12.017_bib297","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.numecd.2020.07.044","article-title":"Abnormal glucose tolerance in a pediatric cystic fibrosis cohort: trends in clinical outcomes and associated factors in the preceding years","volume":"31","author":"Nguyen","year":"2021","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.clnu.2023.12.017_bib298","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jcf.2021.06.004","article-title":"The association between body composition, leptin levels and glucose dysregulation in youth with cystic fibrosis","volume":"20","author":"Granados","year":"2021","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"issue":"Suppl 2","key":"10.1016\/j.clnu.2023.12.017_bib299","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jcf.2019.08.016","article-title":"Cystic fibrosis related diabetes: pathophysiology, screening and diagnosis","volume":"18","author":"Granados","year":"2019","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib300","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jcf.2019.01.009","article-title":"The main mechanism associated with progression of glucose intolerance in older patients with cystic fibrosis is insulin resistance and not reduced insulin secretion capacity","volume":"18","author":"Colomba","year":"2019","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib301","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jcf.2016.04.004","article-title":"Variation of glucose tolerance in adult patients with cystic fibrosis: what is the potential contribution of insulin sensitivity?","volume":"15","author":"Boudreau","year":"2016","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib302","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jcf.2015.02.009","article-title":"Insulin secretion abnormalities in exocrine pancreatic sufficient cystic fibrosis patients","volume":"14","author":"Wooldridge","year":"2015","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib303","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jcf.2013.06.001","article-title":"Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test","volume":"13","author":"Schmid","year":"2014","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib304","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.diabres.2015.10.007","article-title":"Glucose intolerance in cystic fibrosis as a determinant of pulmonary function and clinical status","volume":"110","author":"Lavie","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.clnu.2023.12.017_bib305","first-page":"45","article-title":"Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients","volume":"65","author":"Clemente Leon","year":"2018","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)."},{"key":"10.1016\/j.clnu.2023.12.017_bib306","doi-asserted-by":"crossref","first-page":"e1444","DOI":"10.1210\/clinem\/dgab857","article-title":"Continuous glucose monitoring and HbA1c in cystic fibrosis: clinical correlations and implications for CFRD diagnosis","volume":"107","author":"Scully","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnu.2023.12.017_bib307","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jcjd.2021.03.005","article-title":"Glycated hemoglobin as a first-line screening test for cystic fibrosis\u2012related diabetes and impaired glucose tolerance in children with cystic fibrosis: a validation study","volume":"45","author":"Racine","year":"2021","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.clnu.2023.12.017_bib308","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.659728","article-title":"Continuous glucose monitoring as a valuable tool in the early detection of diabetes related to cystic fibrosis","volume":"9","author":"Gojsina","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.clnu.2023.12.017_bib309","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250036","article-title":"Use of hemoglobin A1c to identify dysglycemia in cystic fibrosis","volume":"16","author":"Darukhanavala","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.clnu.2023.12.017_bib310","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcf.2016.02.005","article-title":"Glycated hemoglobin cannot yet be proposed as a screening tool for cystic fibrosis related diabetes","volume":"15","author":"Boudreau","year":"2016","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib311","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jcjd.2018.11.005","article-title":"Validation of a stepwise approach using glycated hemoglobin levels to reduce the number of required oral glucose tolerance tests to screen for cystic fibrosis-related diabetes in adults","volume":"43","author":"Boudreau","year":"2019","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.clnu.2023.12.017_bib312","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1007\/s00125-021-05423-5","article-title":"Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis","volume":"64","author":"Bonhoure","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnu.2023.12.017_bib313","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jcf.2014.05.006","article-title":"Adherence to clinical care guidelines for cystic fibrosis-related diabetes in 659 German\/Austrian patients","volume":"13","author":"Scheuing","year":"2014","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib314","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jcf.2019.07.010","article-title":"The association of pediatric cystic fibrosis-related diabetes screening on clinical outcomes by center: a CF patient registry study","volume":"19","author":"Franck Thompson","year":"2020","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib315","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jcf.2020.04.004","article-title":"Dyslipidemia is not associated with the development of glucose intolerance or diabetes in cystic fibrosis","volume":"19","author":"Colomba","year":"2020","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib316","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.dsx.2014.09.016","article-title":"Influence of macrolides, nutritional support and respiratory therapies in diabetes and normal glucose tolerance in cystic fibrosis. A retrospective analysis of a cohort of adult and younger patients","volume":"9","author":"Megias","year":"2015","journal-title":"Diabetes Metabol Syndr"},{"key":"10.1016\/j.clnu.2023.12.017_bib317","doi-asserted-by":"crossref","first-page":"e3901","DOI":"10.1210\/clinem\/dgab384","article-title":"Combined indeterminate and impaired glucose tolerance is a novel group at high risk of cystic fibrosis-related diabetes","volume":"106","author":"Potter","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnu.2023.12.017_bib318","doi-asserted-by":"crossref","DOI":"10.1177\/11795514211038259","article-title":"Associations between glucose tolerance, insulin secretion, muscle and fat mass in cystic fibrosis","volume":"14","author":"Nielsen","year":"2021","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"10.1016\/j.clnu.2023.12.017_bib319","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S2213-8587(17)30400-X","article-title":"Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial","volume":"6","author":"Ballmann","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.clnu.2023.12.017_bib320","series-title":"Randomized, controlled trial of Sitagliptin and islet function in cystic fibrosis with abnormal glucose tolerance","author":"Kelly","year":"2021"},{"key":"10.1016\/j.clnu.2023.12.017_bib321","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1210\/clinem\/dgab365","article-title":"Effect of Sitagliptin on islet function in pancreatic insufficient cystic fibrosis with abnormal glucose tolerance","volume":"106","author":"Kelly","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnu.2023.12.017_bib322","first-page":"CD004730","article-title":"Drug treatments for managing cystic fibrosis-related diabetes","volume":"10","author":"Onady","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2023.12.017_bib323","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/dom.13544","article-title":"Exenatide corrects postprandial hyperglycaemia in young people with cystic fibrosis and impaired glucose tolerance: a randomized crossover trial","volume":"21","author":"Geyer","year":"2019","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.clnu.2023.12.017_bib324","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/1747-0080.12604","article-title":"Carbohydrate counting accuracy in adults with cystic fibrosis related diabetes","volume":"77","author":"Stonestreet","year":"2020","journal-title":"Nutr Diet"},{"key":"10.1016\/j.clnu.2023.12.017_bib325","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/1747-0080.12241","article-title":"Nutritional management of cystic fibrosis and cystic fibrosis-related diabetes in Australia","volume":"73","author":"McFarlane","year":"2016","journal-title":"Nutr Diet"},{"key":"10.1016\/j.clnu.2023.12.017_bib326","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jcjd.2016.05.007","article-title":"Glucose fluctuations are not modulated by the proportion of calories from macronutrients or spontaneous total energy expenditure in adults with cystic fibrosis","volume":"40","author":"Ziai","year":"2016","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.clnu.2023.12.017_bib327","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/j.clnu.2019.11.004","article-title":"Dietary intake in cystic fibrosis and its role in glucose metabolism","volume":"39","author":"Armaghanian","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib328","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.clnu.2014.08.016","article-title":"Carbohydrate intake and insulin requirement in children, adolescents and young adults with cystic fibrosis-related diabetes: a multicenter comparison to type 1 diabetes","volume":"34","author":"Scheuing","year":"2015","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib329","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1249\/MSS.0000000000001104","article-title":"Combined exercise training improves glycemic control in adult with cystic fibrosis","volume":"49","author":"Beaudoin","year":"2017","journal-title":"Med Sci Sports Exerc"},{"issue":"Suppl 2","key":"10.1016\/j.clnu.2023.12.017_bib330","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.jcf.2019.08.004","article-title":"Hypoglycemia in cystic fibrosis: prevalence, impact and treatment","volume":"18","author":"Moheet","year":"2019","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"issue":"Suppl 2","key":"10.1016\/j.clnu.2023.12.017_bib331","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.jcf.2017.07.002","article-title":"Cystic fibrosis-related cirrhosis","volume":"16","author":"Leung","year":"2017","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib332","first-page":"20","article-title":"The use of medium-chain triglycerides in gastrointestinal disorders","volume":"160","author":"Shah","year":"2017","journal-title":"Practical Gastroenterol"},{"key":"10.1016\/j.clnu.2023.12.017_bib333","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/MPG.0000000000000501","article-title":"ESPGHAN position paper on management of percutaneous endoscopic gastrostomy in children and adolescents","volume":"60","author":"Heuschkel","year":"2015","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib334","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.dld.2005.01.022","article-title":"Ultrasound guidance in the placement of a percutaneous endoscopic gastrostomy (PEG): an adjuvant technique in patients with abdominal wall varices?","volume":"37","author":"H\u00f6roldt","year":"2005","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clnu.2023.12.017_bib335","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jcf.2019.06.004","article-title":"Self-reported alcohol use in the cystic fibrosis community","volume":"19","author":"Lowery","year":"2020","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib336","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00274-19","article-title":"Altered stool microbiota of infants with cystic fibrosis shows a reduction in genera associated with immune programming from birth","volume":"201","author":"Antosca","year":"2019","journal-title":"J\u00a0Bacteriol"},{"key":"10.1016\/j.clnu.2023.12.017_bib337","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/metabo11020123","article-title":"Impact of altered gut microbiota and its metabolites in cystic fibrosis","volume":"11","author":"Thavamani","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.clnu.2023.12.017_bib338","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.3390\/nu13051716","article-title":"Gut microbiota, in the halfway between nutrition and lung function","volume":"13","author":"Esp\u00edrito Santo","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2023.12.017_bib339","series-title":"Pediatr pulmonol: WILEY-BLACKWELL 111 RIVER ST, HOBOKEN 07030-5774, NJ USA","first-page":"407","article-title":"Probiotic use and antibiotic associated gastrointestinal symptoms in pediatric patients with cystic fibrosis","author":"Sullivan","year":"2015"},{"key":"10.1016\/j.clnu.2023.12.017_bib340","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/j.jcf.2017.07.018","article-title":"Exploring probiotic use in a regional cystic fibrosis consortium","volume":"17","author":"Gonzalez","year":"2018","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib341","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/MPG.0000000000000187","article-title":"Lactobacillus reuteri ATCC55730 in cystic fibrosis","volume":"58","author":"Di Nardo","year":"2014","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib342","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jcf.2014.02.007","article-title":"Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: a double blind prospective study","volume":"13","author":"del Campo","year":"2014","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib343","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41430-017-0043-4","article-title":"Effect of synbiotic supplementation in children and adolescents with cystic fibrosis: a randomized controlled clinical trial","volume":"72","author":"de Freitas","year":"2018","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib344","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jcf.2017.10.014","article-title":"Lack of efficacy of Lactobacillus GG in reducing pulmonary exacerbations and hospital admissions in children with cystic fibrosis: a randomised placebo controlled trial","volume":"17","author":"Bruzzese","year":"2018","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087796","article-title":"Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: a randomised clinical trial","volume":"9","author":"Bruzzese","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clnu.2023.12.017_bib346","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40795-020-00373-4","article-title":"Does synbiotic supplementation affect the quality of life in children with cystic fibrosis? A pilot randomized controlled clinical trial","volume":"6","author":"Bilan","year":"2020","journal-title":"BMC Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib347","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.clnesp.2018.06.008","article-title":"Probiotics in cystic fibrosis patients: a double blind crossover placebo controlled study: pilot study from the ESPGHAN Working Group on Pancreas\/CF","volume":"27","author":"Van Biervliet","year":"2018","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.clnu.2023.12.017_bib348","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174463","article-title":"Abdominal symptoms in cystic fibrosis and their relation to genotype, history, clinical and laboratory findings","volume":"12","author":"Tabori","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.clnu.2023.12.017_bib349","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/17476348.2017.1280399","article-title":"Adherence to therapies in cystic fibrosis: a targeted literature review","volume":"11","author":"Narayanan","year":"2017","journal-title":"Expet Rev Respir Med"},{"key":"10.1016\/j.clnu.2023.12.017_bib350","first-page":"1527","article-title":"Real-world outcomes of ivacaftor treatment in people with cystic fibrosis: a systematic review","volume":"10","author":"Duckers","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.clnu.2023.12.017_bib351","first-page":"CD010966","article-title":"Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del)","volume":"12","author":"Southern","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2023.12.017_bib352","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnu.2023.12.017_bib353","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106646","article-title":"Effectiveness and safety of elexacaftor\/tezacaftor\/ivacaftor in patients with cystic fibrosis and advanced lung disease with the Phe508del\/minimal function genotype","volume":"189","author":"Carnovale","year":"2021","journal-title":"Respir Med"},{"key":"10.1016\/j.clnu.2023.12.017_bib354","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.clnu.2023.12.017_bib355","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1164\/rccm.201906-1227OC","article-title":"Real-life safety and effectiveness of lumacaftor\u2013ivacaftor in patients with cystic fibrosis","volume":"201","author":"Burgel","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clnu.2023.12.017_bib356","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jcf.2019.12.015","article-title":"Clinical effect of lumacaftor\/ivacaftor in F508del homozygous CF patients with FEV(1) >\/= 90% predicted at baseline","volume":"19","author":"Aalbers","year":"2020","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib357","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jand.2020.03.014","article-title":"Effect of CFTR modulators on anthropometric parameters in individuals with cystic fibrosis: an evidence analysis center systematic review","volume":"121","author":"Bailey","year":"2021","journal-title":"J\u00a0Acad Nutr Diet"},{"key":"10.1016\/j.clnu.2023.12.017_bib358","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A\u00a0CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnu.2023.12.017_bib359","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s10620-015-3834-2","article-title":"Nutritional status improved in cystic fibrosis patients with the G551D mutation after treatment with ivacaftor","volume":"61","author":"Borowitz","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clnu.2023.12.017_bib360","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2020.111124","volume":"85","author":"King","year":"2021","journal-title":"Nutrition"},{"key":"10.1016\/j.clnu.2023.12.017_bib361","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jcf.2021.11.012","article-title":"Effect of elexacaftor-tezacaftor-ivacaftor on body weight and metabolic parameters in adults with cystic fibrosis","volume":"21","author":"Petersen","year":"2022","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib362","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jpeds.2018.05.018","article-title":"Energy balance and mechanisms of weight gain with ivacaftor treatment of cystic fibrosis gating mutations","volume":"201","author":"Stallings","year":"2018","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2023.12.017_bib363","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1038\/ctg.2017.10","article-title":"Impact of CFTR modulation on intestinal pH, motility, and clinical outcomes in patients with cystic fibrosis and the G551D mutation","volume":"8","author":"Gelfond","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.clnu.2023.12.017_bib364","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3390\/antiox10030483","article-title":"CFTR modulator therapy with lumacaftor\/ivacaftor alters plasma concentrations of lipid-soluble vitamins A and E in patients with cystic fibrosis","volume":"10","author":"Sommerburg","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.clnu.2023.12.017_bib365","series-title":"Nutritional status and circulating levels of fat-soluble vitamins in cystic fibrosis patients: a cohort study and evaluation of the effect of CFTR modulators","first-page":"10","author":"Francalanci","year":"2023"},{"key":"10.1016\/j.clnu.2023.12.017_bib366","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/j.jcf.2022.01.010","article-title":"Hypervitaminosis A with fulminant secondary intracranial hypertension following personalized medicine-based Elexacaftor\/Tezacaftor\/Ivacaftor initiation in a preadolescent with cystic fibrosis","volume":"21","author":"Wisniewski","year":"2022","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib367","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1513\/AnnalsATS.202006-614RL","article-title":"Appearance of pancreatic sufficiency and discontinuation of pancreatic enzyme replacement therapy in children with cystic fibrosis on ivacaftor","volume":"18","author":"Hutchinson","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.clnu.2023.12.017_bib368","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.877118","article-title":"Elexacaftor-tezacaftor-ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-score","volume":"13","author":"Mainz","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.clnu.2023.12.017_bib369","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36364-6","article-title":"Impact of CFTR modulation with ivacaftor on gut microbiota and intestinal inflammation","volume":"8","author":"Ooi","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.clnu.2023.12.017_bib370","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/MPG.0000000000002864","article-title":"Reduced intestinal inflammation with lumacaftor\/ivacaftor in adolescents with cystic fibrosis","volume":"71","author":"Tetard","year":"2020","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib371","article-title":"Real-world safety of CFTR modulators in the treatment of cystic fibrosis: a systematic review","volume":"10","author":"Dagenais","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.clnu.2023.12.017_bib372","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcf.2021.09.001","article-title":"The effect of elexacaftor\/tezacaftor\/ivacaftor (ETI) on glycemia in adults with cystic fibrosis","volume":"21","author":"Scully","year":"2022","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib373","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jcf.2019.05.015","article-title":"Disease progression in patients with cystic fibrosis treated with ivacaftor: data from national US and UK registries","volume":"19","author":"Volkova","year":"2020","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib374","series-title":"Call for changes in lung allocation to reduce transplant wait-list mortality for cystic fibrosis","first-page":"956","author":"Nolley","year":"2019"},{"key":"10.1016\/j.clnu.2023.12.017_bib375","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1164\/rccm.201902-0252OC","article-title":"Effect of including important clinical variables on accuracy of the lung allocation score for cystic fibrosis and chronic obstructive pulmonary disease","volume":"200","author":"Lehr","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clnu.2023.12.017_bib376","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jcf.2021.12.001","article-title":"Low body mass index as a barrier to lung transplant in cystic fibrosis","volume":"21","author":"Jennerich","year":"2022","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib377","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1164\/rccm.200410-1369OC","article-title":"Risk factors for death of patients with cystic fibrosis awaiting lung transplantation","volume":"173","author":"Belkin","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clnu.2023.12.017_bib378","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.healun.2022.07.017","article-title":"Frailty predicts outcomes in cystic fibrosis patients listed for lung transplantation","volume":"41","author":"Koutsokera","year":"2022","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.clnu.2023.12.017_bib379","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S1053-2498(00)00315-6","article-title":"Nutritional assessment of the lung transplant patient: body mass index as a predictor of 90-day mortality following transplantation","volume":"20","author":"Madill","year":"2001","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.clnu.2023.12.017_bib380","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13111","article-title":"Lung transplantation in cystic fibrosis patients in Israel: the importance of ethnicity and nutritional status","volume":"31","author":"Levine","year":"2017","journal-title":"Clin Transplant"},{"key":"10.1016\/j.clnu.2023.12.017_bib381","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.chest.2019.11.043","article-title":"Underweight patients with cystic fibrosis have acceptable survival following lung transplantation: a united Network for organ sharing registry study","volume":"157","author":"Ramos","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.clnu.2023.12.017_bib382","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.healun.2012.11.002","article-title":"Body mass index and its effect on outcome in children after lung transplantation","volume":"32","author":"Benden","year":"2013","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.clnu.2023.12.017_bib383","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1513\/AnnalsATS.202108-969OC","article-title":"Body mass index recovery after lung transplant for cystic fibrosis","volume":"19","author":"Pryor","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.clnu.2023.12.017_bib384","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jclinepi.2014.12.010","article-title":"A\u00a0statistical model to predict one-year risk of death in patients with cystic fibrosis","volume":"68","author":"Aaron","year":"2015","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.clnu.2023.12.017_bib385","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcf.2019.03.002","article-title":"Lung transplant referral for individuals with cystic fibrosis: cystic Fibrosis Foundation consensus guidelines","volume":"18","author":"Ramos","year":"2019","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib386","article-title":"Obesity in cystic fibrosis","volume":"26","author":"Kutney","year":"2021","journal-title":"J\u00a0Clin Transl Endocrinol"},{"key":"10.1016\/j.clnu.2023.12.017_bib387","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/088453369701200504","article-title":"Improvement in the nutritional and pulmonary profiles of cystic fibrosis patients undergoing bilateral sequential lung and heart-lung transplantation","volume":"12","author":"Beck","year":"2016","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnu.2023.12.017_bib388","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jcf.2020.03.013","article-title":"Resting energy expenditure in cystic fibrosis patients decreases after lung transplantation, which improves applicability of prediction equations for energy requirement","volume":"19","author":"Hollander-Kraaijeveld","year":"2020","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib389","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.jpeds.2013.05.063","article-title":"Energy expenditure and nutritional status in pediatric patients before and after lung transplantation","volume":"163","author":"Kalnins","year":"2013","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2023.12.017_bib390","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/0884533616645819","article-title":"Prediction equations underestimate resting energy expenditure in patients with end-stage cystic fibrosis","volume":"32","author":"Hollander","year":"2017","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnu.2023.12.017_bib391","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jcf.2020.09.012","article-title":"Long-term bone mineral density changes and fractures in lung transplant recipients with cystic fibrosis","volume":"20","author":"Durette","year":"2021","journal-title":"J\u00a0Cyst Fibros : Off J Eur Cystic Fibr Soci"},{"key":"10.1016\/j.clnu.2023.12.017_bib392","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3148\/cjdpr-2016-014","article-title":"Bone mineral density and fat-soluble vitamin status in adults with cystic fibrosis undergoing lung transplantation: a pilot study","volume":"77","author":"Hubert","year":"2016","journal-title":"Can J Diet Pract Res"},{"key":"10.1016\/j.clnu.2023.12.017_bib393","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212779","article-title":"The emerging burden of liver disease in cystic fibrosis patients: a UK nationwide study","volume":"14","author":"Toledano","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.clnu.2023.12.017_bib394","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1432-2277.2004.00013.x","article-title":"Effects of liver transplantation on the nutritional status of patients with cystic fibrosis","volume":"18","author":"Colombo","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.clnu.2023.12.017_bib395","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/ajt.16791","article-title":"Liver transplant in children and adults with cystic fibrosis: impact of growth failure and nutritional status","volume":"22","author":"Cheng","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.clnu.2023.12.017_bib396","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1600-6143.2011.03904.x","article-title":"Long-term impact of liver transplantation on respiratory function and nutritional status in children and adults with cystic fibrosis","volume":"12","author":"Dowman","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.clnu.2023.12.017_bib397","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/MPG.0000000000003194","article-title":"Survival benefits following liver transplantation: a matched-pair analysis in pediatric patients with cystic fibrosis","volume":"73","author":"Flemming","year":"2021","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2023.12.017_bib398","article-title":"Bone mineral density in cystic fibrosis patients with the CFTR I1234V mutation in a large kindred family is associated with pancreatic sufficiency","volume":"2014","author":"Wahab","year":"2014","journal-title":"Internet J Rheumatol"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561423004570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561423004570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T01:16:23Z","timestamp":1759367783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561423004570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":398,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0261561423004570"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2023.12.017","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ESPEN-ESPGHAN-ECFS guideline on nutrition care for cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2023.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}